Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-759-7 | CAS number: 16712-64-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Two acute oral toxicity studies are available for the read-across substance, 3-hydroxy-2-naphthoic acid. The effect level for oral toxicity was using the most conservative (lowest LD50) value from the female animals of the Key Study. In the Acute Inhalation study of the substance of record, 6-hydroxy-2-naphthoic acid, no systemic effects were observed. The only observed effect was slight reversible irritation of the oral and respiratory mucous membranes consistent with mechanical irritation.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1983-09-27 - 1983-12-2
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline conforming study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- of 1981
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hoechst AG breeding colony
- Weight at study initiation: male 197 g (mean); female 191 g (mean)
- Fasting period before study: 16h
- Housing: makrolon cage, groups of 5
- Diet (e.g. ad libitum): rat diet Altromin 1324, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): 55 +/- 10
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 2% aqueous carboxymethyl cellulose (CMC)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 25%
- Amount of vehicle (if gavage): 1.25ml/kg bw in the lowest dose group and 5.0 ml/kg bw in the highest dose group - Doses:
- male: 800, 1000, 1250 mg/kg bw
female: 315, 500, 800, 1000, 1250 mg/kg bw - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
weighth was determined: 0, 7, 14 days post application,
clinical signes were observed: 10, 30, 60 min; 2, 4, 6 h, 1, 2, 3, 4-14 d post application
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- Probit analysis
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 823 mg/kg bw
- 95% CL:
- >= 581 - <= 1 070
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 869 mg/kg bw
- 95% CL:
- >= 394 - <= 1 350
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 795 mg/kg bw
- 95% CL:
- >= 485 - <= 1 320
- Mortality:
- 315 mg/kg bw : 0/5 (f)
500 mg/kg bw: 2/5 (f)
800 mg/kg bw: 1/5 (m), 2/5 (f)
1000 mg/kg bw: 3/5 (m), 3/5 (f)
1250 mg/kg bw: 5/5 (m), 4/5 (f)
all deaths occured 35 - 200 min. post application - Clinical signs:
- other: Similar clinical signs were observed in both sexes. Clinical signes included reduced activity, accelerated breathing, closure of eyes and diarrhea (occurring 30-60 min post application).
- Gross pathology:
- Surviving animals were free of pathological changes at the end of the observation period (14 d). Gastrointestinal irritation and dark or mottled livers were observed in the dead animals.
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information REGULATION (EC) No 1272/2008 Criteria used for interpretation of results: EU
- Conclusions:
- LD50 male/female: 823 mg/kg bw
LD50 male: 869 mg/kg bw
LD50 female: 795 mg/kg bw - Executive summary:
3-Hydroxy-2-naphthoic acid was tested for its acute toxicity in the rat according to OECD Guideline 401 and in compliance with GLP. An oral LD50 of 823 mg/kg bw was determined for both sexes, 869 mg/kg for males and 795 mg/kg for females. Mortality occurred within 35 -200 minutes after dosing. Principal clinical signs were reduced spontaneous activity, ventral and lateral recumbency and crawling in all dose groups, in addition to closure of eyes, hunched posture and accelarated breathing in several dose groups starting at approximately 10 to 30 min post administration. In addition, diarrhea was noted in several dose groups starting mainly at approximately 30 to 60 min post administration. As from the day after the administration all surviving animals were free from clinical signs. Bodyweight was unaffected by treatment with the test substance. No macroscopic pathology findings were evident in animals which survived the 14-day post-dosing observation period, whilst dark or mottled livers and signs of gastrointestinal irritation were evident in decedent animals. There was no indication of relevant sex-related differences in toxicity of the substance after single oral administration.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 795 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No GLP statement; However, is a well-conducted, well-documented study.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: Sprague-Dawley derived CD
- Source: Charles River Breeding Laboratories, Wilmington, MA, USA
- Date received: 29 July 1980
- Age at study initiation: Not given
- Weight at study initiation: Males, 290-300 grams; Females, 210-249 grams
- Fasting period before study: Not stated.
- Housing: Not stated.
- Diet (e.g. ad libitum): Not stated.
- Water (e.g. ad libitum): Not stated.
- Acclimation period: Not stated.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): mean temperature was 21 degrees C during exposure.
- Humidity (%): mean relative humidity was 74% during exposure.
- Air changes (per hr): Not given. Study report gives air flow rate of "15 liters per minute" and states that "test material was delivered in a total volume of 3600 L of air".
- Photoperiod (hrs dark / hrs light): Not stated.
IN-LIFE DATES: Not stated. - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Plexiglass Exposure Chamber
- Exposure chamber volume: 100 L
- Method of holding animals in test chamber: Closed Chamber
- Source and rate of air: Source not stated, rate given as 15 liters per minute.
- Method of conditioning air: Described only as "dry air".
- System of generating particulates/aerosols: Test material was press-packed into a Wright Dust Feed cylinder using a Carver Hydraulic Press at a pressure of 1500 psi. The Wright Dust Feed mechanism, set at a gear ratio of 1.5 to 1 was arranged to feed into the exposure chamber. Dry air at a flow rate of 15 liters per minute was passed through the dust feed mechanisms to generate the dust, which was directed undiluted into the exposure chamber.
- Method of particle size determination: Particle size distribution samples were taken at half-hour intervals using a Casella cascade impactor. The distribution was calculated based on the amount of material collected on the impactor stages.
- Treatment of exhaust air: Not stated.
- Temperature, humidity, pressure in air chamber: mean chamber temperature of 21 degrees C, and relative humidity of 74% during exposure.
TEST ATMOSPHERE
- Brief description of analytical method used:
- Samples taken from breathing zone: yes/no
VEHICLE
- Composition of vehicle (if applicable): Air
- Concentration of test material in vehicle (if applicable): mean airborne test material concentration given as 0.51 mg/Liter air.
- Justification of choice of vehicle: Most relevant vehicle for this route of administration.
- Lot/batch no. (if required): Not applicable.
- Purity: Not given.
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: Not given.
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): Aerodynamic Mass Median Diameter of 3.61 micron, with Geometric Standard Deviation Range of 2.21 to 6.55. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Total airborne concentration measured hourly.
- Duration of exposure:
- 4 h
- Concentrations:
- Nominal concentration of 3.8 mg/Liter.
- No. of animals per sex per dose:
- 5 animals per sex, only one dose level evaluated.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days.
- Frequency of observations and weighing: Animals were observed for abnormal signs before exposure, every 15 minutes during the first hour of exposure, hourly through the rest of the exposure period, hourly for four hours post-exposure, and daily thereafter for 14 days.
- Necropsy of survivors performed: yes
- Other examinations performed: - Sex:
- male/female
- Dose descriptor:
- other: slight reversible irritation of the oral and respiratory mucous membranes.
- Effect level:
- 3.8 mg/L air (nominal)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No animals died during the exposure period, or the during the subsequent 14-day observation period.
- Clinical signs:
- other: During exposure, animals were noted to be "huddled together in the chamber." In addition, some animals were observed to be rubbing their eyes, and some were noted to have labored breathing and wet and/or matted fur. After removal from the chamber, most
- Body weight:
- Although small, transient weight losses were observed in most rats, body weights recovered to pre-exposure values in Males by Day 7, and in females by Day 14.
- Gross pathology:
- At necropsy, 4 males and 3 females showed foci of lung discoloration. However, these were determined to be common pathological entities in this particular strain of rats, and was deemed to not be related to the test material.
- Interpretation of results:
- relatively harmless
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- A four-hour acute inhalation exposure to a dust of test material at a nominal concentration of 3.8 mg/L with an aerodynamic mass median diameter of 3.61 microns and geometric standard deviation range of 2.21 to 6.55 did not produce mortality, but caused a slight reversible irritation of the oral and respiratory mucous membranes. Also observed was slight neuro-muscular impairment during the 4 hour post-exposure observation period.
- Executive summary:
A four-hour acute inhalation exposure to a dust of test material at a nominal concentration of 3.8 mg/L with an aerodynamic mass median diameter of 3.61 microns and geometric standard deviation range of 2.21 to 6.55 did not produce mortality, but caused a slight reversible irritation of the oral and respiratory mucous membranes. Also observed was slight neuro-muscular impairment during the 4 hour post-exposure observation period.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
The acute inhalation toxicity of the substance of record, 6 -hydroxy-2 -naphthoic acid (6 -HNA) was determined. As there were no mortalities, and the only observed effects were consistent with mechanical irritation attributed to the inhalation of particulate matter, no inhalation effect level could be established. Regarding oral toxicity, two separate studies on the read-across substance, 3 -hydroxy-2 -naphthoic acid (3 -HNA) consistently gave LD50 values which would place it (and structurally-related substances) into Toxicity Category IV, according to Regulation (EC) No 1272/2008.
Justification for selection of acute toxicity – oral endpoint
Two Acute Oral Toxicity studies are available for the read-across substance, 3-hydroxy-2 naphthoic acid. The lowest LD50 value for either males or females across both studies was 795 mg/kg body weight.
Justification for classification or non-classification
Classification as Oral Toxicity Category IV is based on the absence of inhalation effects, and oral LD50 values for the read-across substance, which fell consistently in the Toxicity Category IV group.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.